The Muitivial Dose Lidocaine can be Contaminated by Body Secretion
Keywords:
multivial dose, lidocaine, contaminated, body, secretionAbstract
Introduction: We use multivial dose lidocain in many procedures, and find chances of contamination by using multivial dose lidocaine.
Objective: To prove a chance of body secretion contamination by using multivial dose lidocaine
Material and Method: We test by using multivial dose lidocaine and draw lidocaine by using the same syringe 2 times (while there is still some lidocaine left in the first syringe). Then we use questionaire to ask 50 physicians about how they draw lidocaine from multivial dose lidocaine. After that, we show them that using the same syringe can cause serious body secretion contamination. After giving them that information, We then ask them the same question again.
Result: The use of the same syringe in multivial dose lidocaine can cause serious body fluid contamination in the lidocaine vial. Eighty four percent of physicians use the same syringe when they draw lidocaine from the same vial. After they receive the information, 2% still do it the same way, 90% will change syringe every time, and 8% will change lidocaine vial every time.
Conclusion: We suggest physicians to change syringe every time or change lidocaine vial when we need more lidocaine.
References
Bruguera M, Saiz JC, Franco S, Giménez-Barcons M, Sánchez-Tapias JM, Fabregas S, et al. Outbreak of nosocomial hepatitis C virus infection resolved by genetic analysis of HCV RNA. J Clin Microbiol. 2002; 40(11): 4363-6.
Paparella S. The risks associated with the use of multidose vials. J Emerg Nurs. 2006; 32(5): 428-30.
Blank S, Simonds RJ, Weisfuse I, Rudnick J, Chiasson MA, Thomas P. Possible nosocomial transmission of HIV. Lancet. 1994 20; 344(8921): 512-4.
Krause G, Trepka MJ, Whisenhunt RS, Katz D, Nainan O, Wiersma ST, et al. Nosocomial transmission of hepatitis C virus associated with the use of multidose saline vials. Infect Control Hosp Epidemiol. 2003; 24(2): 122-7.
